Compare Stocks: CVRX, TLSI, ELMD, and PDEX

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CVRX CVRx	$1.56 +0.3%	$3.25	$1.50 ▼ $11.30	$41.69M	0.77	527,730 shs	423,987 shs
ELMD Electromed	$28.41 +1.1%	$33.62	$23.01 ▼ $47.40	$234.37M	0.4	78,806 shs	44,338 shs
PDEX Pro-Dex	$65.35 +2.0%	$65.96	$23.47 ▼ $77.00	$210.19M	0.04	51,885 shs	32,183 shs
TLSI TriSalus Life Sciences	$4.39 +1.6%	$4.90	$2.20 ▼ $7.95	$270.21M	0.47	307,684 shs	61,064 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CVRX CVRx	0.00%	-42.59%	-49.18%	-72.47%	-82.20%
ELMD Electromed	0.00%	+0.79%	+0.36%	-39.32%	+12.09%
PDEX Pro-Dex	0.00%	-10.73%	-12.72%	+3.62%	+88.28%
TLSI TriSalus Life Sciences	0.00%	-0.46%	-13.60%	+0.23%	-6.49%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CVRX CVRx	$1.56 +0.3%	$3.25	$1.50 ▼ $11.30	$41.69M	0.77	527,730 shs	423,987 shs
ELMD Electromed	$28.41 +1.1%	$33.62	$23.01 ▼ $47.40	$234.37M	0.4	78,806 shs	44,338 shs
PDEX Pro-Dex	$65.35 +2.0%	$65.96	$23.47 ▼ $77.00	$210.19M	0.04	51,885 shs	32,183 shs
TLSI TriSalus Life Sciences	$4.39 +1.6%	$4.90	$2.20 ▼ $7.95	$270.21M	0.47	307,684 shs	61,064 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CVRX CVRx	0.00%	-42.59%	-49.18%	-72.47%	-82.20%
ELMD Electromed	0.00%	+0.79%	+0.36%	-39.32%	+12.09%
PDEX Pro-Dex	0.00%	-10.73%	-12.72%	+3.62%	+88.28%
TLSI TriSalus Life Sciences	0.00%	-0.46%	-13.60%	+0.23%	-6.49%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CVRX CVRx	2.17	Hold	$4.30	176.53% Upside
ELMD Electromed	2.75	Moderate Buy	$43.75	54.01% Upside
PDEX Pro-Dex	3.00	Buy	$74.00	13.25% Upside
TLSI TriSalus Life Sciences	2.40	Hold	$10.20	132.35% Upside

Current Analyst Ratings Breakdown

Latest CVRX, TLSI, ELMD, and PDEX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/23/2026	TLSI TriSalus Life Sciences	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$12.00
9/23/2026	TLSI TriSalus Life Sciences	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$12.00
9/23/2026	TLSI TriSalus Life Sciences	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$11.00 ➝ $12.00
9/22/2026	CVRX CVRx	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$5.00
9/21/2026	PDEX Pro-Dex	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy (B-) ➝ Hold (C+)
9/15/2026	PDEX Pro-Dex	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
9/11/2026	PDEX Pro-Dex	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$70.00 ➝ $74.00
9/10/2026	TLSI TriSalus Life Sciences	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold
9/9/2026	TLSI TriSalus Life Sciences	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$11.00
9/9/2026	TLSI TriSalus Life Sciences	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$11.00
9/4/2026	PDEX Pro-Dex	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C+) ➝ Buy (B-)

(Data available from 10/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CVRX CVRx	$56.65M	0.73	N/A	N/A	$1.50 per share	1.04
ELMD Electromed	$73.78M	3.19	$0.69 per share	41.36	$5.10 per share	5.57
PDEX Pro-Dex	$77.55M	2.70	$3.98 per share	16.42	$14.92 per share	4.38
TLSI TriSalus Life Sciences	$45.15M	5.99	N/A	N/A	($0.68) per share	-6.46

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CVRX CVRx	-$53.31M	-$1.98	N/A	N/A	N/A	-84.93%	-152.35%	-50.93%	11/4/2026 (Estimated)
ELMD Electromed	$5.15M	$1.31	37.71	N/A	N/A	11.34%	15.71%	13.37%	N/A
PDEX Pro-Dex	$13.66M	$4.13	15.90	19.45	N/A	17.62%	25.13%	16.02%	10/29/2026 (Estimated)
TLSI TriSalus Life Sciences	-$39.23M	-$1.30	N/A	N/A	N/A	-62.59%	N/A	-64.47%	11/12/2026 (Estimated)

Latest CVRX, TLSI, ELMD, and PDEX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
10/29/2026	Q1 2027	PDEX Pro-Dex	$0.67	N/A	N/A	N/A	$20.40 million	N/A
9/3/2026	Q4 2026	PDEX Pro-Dex	$0.67	$0.87	+$0.20	$0.87	$19.20 million	$20.41 million
8/6/2026	Q2 2026	CVRX CVRx	-$0.5246	-$0.53	-$0.0054	-$0.53	$15.55 million	$15.71 million
8/6/2026	Q2 2026	TLSI TriSalus Life Sciences	-$0.1550	-$0.16	-$0.0050	-$0.16	$10.27 million	$11.41 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CVRX CVRx	N/A	N/A	N/A	N/A	N/A
ELMD Electromed	N/A	N/A	N/A	N/A	N/A
PDEX Pro-Dex	N/A	N/A	N/A	N/A	N/A
TLSI TriSalus Life Sciences	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CVRX CVRx	2.94	8.04	6.87
ELMD Electromed	N/A	5.10	4.74
PDEX Pro-Dex	0.28	4.10	2.45
TLSI TriSalus Life Sciences	5.05	5.35	4.97

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CVRX CVRx	75.27%
ELMD Electromed	40.82%
PDEX Pro-Dex	15.28%
TLSI TriSalus Life Sciences	2.58%

Insider Ownership

Company	Insider Ownership
CVRX CVRx	16.60%
ELMD Electromed	10.50%
PDEX Pro-Dex	45.90%
TLSI TriSalus Life Sciences	16.30%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CVRX CVRx	223	26.64 million	22.22 million	Optionable
ELMD Electromed	197	8.29 million	7.36 million	Optionable
PDEX Pro-Dex	206	3.20 million	1.73 million	Not Optionable
TLSI TriSalus Life Sciences	102	61.58 million	51.54 million	Not Optionable

CVRX, TLSI, ELMD, and PDEX Headlines

Recent News About These Companies

TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Stock Has Average Target Price of $10.20 According to Analysts

October 4 at 4:15 AM | americanbankingnews.com

TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Receives Average Rating of "Hold" from Analysts

October 4 at 4:13 AM | marketbeat.com

H.C. Wainwright Keeps Their Buy Rating on TriSalus Life Sciences (TLSI)

October 3 at 8:59 AM | theglobeandmail.com

QT Imaging (NASDAQ:QTI) versus TriSalus Life Sciences (NASDAQ:TLSI) Head to Head Analysis

September 30, 2026 | americanbankingnews.com

TriSalus Life Sciences, Inc. $TLSI Stock Holdings Lifted by State Street Corp

September 27, 2026 | marketbeat.com

TLSI Stock Gets Reduced EPS Estimate from HC Wainwright

September 27, 2026 | americanbankingnews.com

TLSI Stock Gets Reduced EPS Forecast from HC Wainwright

September 25, 2026 | marketbeat.com

Analysts Offer Insights on Healthcare Companies: Faeth Therapeutics (FTH), TriSalus Life Sciences (TLSI) and Immuneering (IMRX)

September 24, 2026 | theglobeandmail.com

Analysts Conflicted on These Healthcare Names: TriSalus Life Sciences (TLSI) and Eli Lilly & Co (LLY)

September 24, 2026 | theglobeandmail.com

TriSalus Life Sciences Shares Rise After Receiving FDA Clearance for TriNav Advance

September 24, 2026 | marketscreener.comM

Update: TriSalus Life Sciences Shares Rise After Receiving FDA Clearance for TriNav Advance

September 23, 2026 | finance.yahoo.com

TriSalus Life Sciences Shares Rise 15.6% After FDA Clearance for TriNav Advance

September 23, 2026 | finance.yahoo.com

TriSalus Life Sciences, Lakefront Biotherapeutics, Editas Medicine And Other Big Stocks Moving Higher On Wednesday

September 23, 2026 | benzinga.com

TriSalus Gets FDA Clearance For TriNav Advance For Liver Embolization; Overnight Stock Up 17%

September 23, 2026 | rttnews.com

TriSalus jumps 16% after FDA clears TriNav Advance device

September 23, 2026 | msn.com

HC Wainwright Forecasts Strong Price Appreciation for TriSalus Life Sciences (NASDAQ:TLSI) Stock

September 23, 2026 | marketbeat.com

TriSalus Life Sciences receives FDA clearance for TriNav Advance device

September 22, 2026 | streetinsider.com

TriSalus Life Sciences Gets FDA Clearance for Drug Delivery Device

September 22, 2026 | marketscreener.comM

TriSalus Life Sciences Gets FDA Clearance for TriNav Advance

September 22, 2026 | finance.yahoo.com

TriSalus Life Sciences Receives FDA Clearance for TriNav® Advance, Strengthening Comprehensive Pressure-Enabled Drug Delivery™ (PEDD™) Portfolio for Liver Embolization

September 22, 2026 | businesswire.com

TriSalus Life Sciences (NASDAQ:TLSI) Upgraded to Hold at Zacks Research

September 12, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

CVRX, TLSI, ELMD, and PDEX Company Descriptions

CVRx NASDAQ:CVRX

$1.56 +0.01 (+0.58%)

As of 04:00 PM Eastern

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Electromed NYSE:ELMD

$28.40 +0.30 (+1.06%)

As of 04:00 PM Eastern

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Pro-Dex NASDAQ:PDEX

$65.45 +1.38 (+2.15%)

As of 04:00 PM Eastern

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

TriSalus Life Sciences NASDAQ:TLSI

$4.39 +0.07 (+1.55%)

As of 04:00 PM Eastern

TriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. The company offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial, for locally advanced pancreatic cancer. It also develops nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma with liver metastases, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and locally advanced pancreatic ductal adenocarcinoma. The company serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. TriSalus Life Sciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CVRX, TLSI, ELMD, and PDEX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CVRX, TLSI, ELMD, and PDEX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CVRX, TLSI, ELMD, and PDEX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

CVRX, TLSI, ELMD, and PDEX Company Descriptions

CVRx NASDAQ:CVRX

Electromed NYSE:ELMD

Pro-Dex NASDAQ:PDEX

TriSalus Life Sciences NASDAQ:TLSI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CVRX, TLSI, ELMD, and PDEX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CVRX, TLSI, ELMD, and PDEX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CVRX, TLSI, ELMD, and PDEX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

CVRX, TLSI, ELMD, and PDEX Company Descriptions

CVRx NASDAQ:CVRX

Electromed NYSE:ELMD

Pro-Dex NASDAQ:PDEX

TriSalus Life Sciences NASDAQ:TLSI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools